Boorjian SA - Search Results

1

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.

Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ. Boorjian SA, et al. Eur Urol. 2011 Jun;59(6):893-9. doi: 10.1016/j.eururo.2011.02.026. Epub 2011 Feb 22. Eur Urol. 2011. PMID: 21388736

2

Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?

Boorjian SA, Bianco FJ Jr, Scardino PT, Eastham JA. Boorjian SA, et al. BJU Int. 2005 Oct;96(6):773-6. doi: 10.1111/j.1464-410X.2005.05763.x. BJU Int. 2005. PMID: 16153197

3

Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?

Vickers AJ, Bianco FJ Jr, Boorjian S, Scardino PT, Eastham JA. Vickers AJ, et al. Cancer. 2006 Feb 1;106(3):576-80. doi: 10.1002/cncr.21643. Cancer. 2006. PMID: 16353213 Free PMC article.

4

Renal cell carcinoma: vena caval involvement.

Boorjian SA, Sengupta S, Blute ML. Boorjian SA, et al. BJU Int. 2007 May;99(5 Pt B):1239-44. doi: 10.1111/j.1464-410X.2007.06826.x. BJU Int. 2007. PMID: 17441917 Review. No abstract available.

5

Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.

Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Blute ML, et al. Among authors: boorjian sa. J Urol. 2007 Aug;178(2):440-5; discussion 444. doi: 10.1016/j.juro.2007.03.121. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561151

6

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342

7

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. Boorjian SA, et al. BJU Int. 2008 Feb;101(3):299-304. doi: 10.1111/j.1464-410X.2007.07269.x. Epub 2007 Oct 8. BJU Int. 2008. PMID: 17922854

8

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Thompson RH, et al. Among authors: boorjian sa. J Urol. 2008 Feb;179(2):468-71; discussion 472-3. doi: 10.1016/j.juro.2007.09.077. J Urol. 2008. PMID: 18076931

9

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.

Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. Boorjian SA, et al. Urology. 2007 Dec;70(6):1064-8. doi: 10.1016/j.urology.2007.07.045. Urology. 2007. PMID: 18158015

10

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Boorjian SA, et al. J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. doi: 10.1016/j.juro.2007.11.061. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters